June 10, 2025

Can Gallbladder Surgery Cut Risk and Costs?

A national study of older adults with multimorbidity found that surgery for acute cholecystitis reduced readmissions, emergency visits, and long-term costs compared to non-operative treatment.

Conexiant

June 09, 2025

EHR Prompts Cut Antibiotic Use by 35%

A 92-hospital trial found that simple prompts in electronic health records helped reduce the use of broad-spectrum antibiotics in low-risk abdominal infection cases—without increasing ICU stays or length of hospitalization.

Conexiant

June 09, 2025

Emergency Surgery? One Frailty Score Leads

A national study of 1.38 million emergency general surgery cases found that one frailty scoring system predicted mortality and complications more accurately than others.

Conexiant

May 30, 2025

Extra Boost Before Surgery Shows Promise

Tevimbra added to chemo before esophageal cancer surgery doubled complete response rates in a phase 2 trial, hinting at a future shift in standard care.

Reuters

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 20, 2025

ICU Sedation Economics: A $1 Difference

Study finds dexmedetomidine, clonidine, and propofol have comparable cost-effectiveness for critically ill patients on mechanical ventilation.

Conexiant

May 19, 2025

No-Touch Technique May Improve CABG Graft Outcomes

A large study of 2,655 CABG patients found that using the no-touch technique to harvest vein grafts significantly reduced blockage, heart attacks, and repeat procedures over three years.

Conexiant

May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 16, 2025

Long-Term Data Support BCT for BRCA-Mutated Breast Cancer

Researchers found that breast-conserving treatment provided long-term survival outcomes comparable to mastectomy in patients with breast cancer and BRCA1 or BRCA2 pathogenic variants.

Conexiant